东方生物：新冠抗原检测试剂(专业版)所取得CLIA证书近日生效

智通财经11-14 16:35

智通财经APP讯，东方生物(688298.SH)公告，公司全资子公司美国衡健生物科技有限公司(简称“美国衡健”)的新冠抗原检测试剂(专业版)取得的CLIA证书近日生效，同时获得加拿大医疗器械注册证;控股子公司杭州莱和生物技术有限公司(简称“杭州莱和”)的四款毒品检测试剂近日取得由国家药品监督管理局(简称“NMPA”)颁发的《医疗器械注册证》(体外诊断试剂);另外，公司参与研制或生产的两款动物检测...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2483996847?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-14 16:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2483996847","market":"sh","top_or_hot":-1,"title":"东方生物：新冠抗原检测试剂(专业版)所取得CLIA证书近日生效","media":"智通财经","content":"<div>\n<p>智通财经APP讯，东方生物(688298.SH)公告，公司全资子公司美国衡健生物科技有限公司(简称“美国衡健”)的新冠抗原检测试剂(专业版)取得的CLIA证书近日生效，同时获得加拿大医疗器械注册证;控股子公司杭州莱和生物技术有限公司(简称“杭州莱和”)的四款毒品检测试剂近日取得由国家药品监督管理局(简称“NMPA”)颁发的《医疗器械注册证》(体外诊断试剂);另外，公司参与研制或生产的两款动物检测...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163813abc06181&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>东方生物：新冠抗原检测试剂(专业版)所取得CLIA证书近日生效</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n东方生物：新冠抗原检测试剂(专业版)所取得CLIA证书近日生效\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 16:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163813abc06181&s=b><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，东方生物(688298.SH)公告，公司全资子公司美国衡健生物科技有限公司(简称“美国衡健”)的新冠抗原检测试剂(专业版)取得的CLIA证书近日生效，同时获得加拿大医疗器械注册证;控股子公司杭州莱和生物技术有限公司(简称“杭州莱和”)的四款毒品检测试剂近日取得由国家药品监督管理局(简称“NMPA”)颁发的《医疗器械注册证》(体外诊断试剂);另外，公司参与研制或生产的两款动物检测...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163813abc06181&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163813abc06181&s=b","article_id":"2483996847","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163813abc06181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2483996847","pubTimestamp":1731573341,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"智通财经APP讯，东方生物(688298.SH)公告，公司全资子公司美国衡健生物科技有限公司(简称“美国衡健”)的新冠抗原检测试剂(专业版)取得的CLIA证书近日生效，同时获得加拿大医疗器械注册证;控股子公司杭州莱和生物技术有限公司(简称“杭州莱和”)的四款毒品检测试剂近日取得由国家药品监督管理局(简称“NMPA”)颁发的《医疗器械注册证》(体外诊断试剂);另外，公司参与研制或生产的两款动物检测试剂被纳入由中华人民共和国农业农村部审查批准核发的新兽药注册目录/兽药产品目录。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688298":"东方生物","BK0239":"医药制造"},"translate_title":"Oriental Bio: The CLIA certificate obtained by the new crown antigen detection reagent (professional version) has recently taken effect","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688298":1},"content_text":"智通财经APP讯，东方生物(688298.SH)公告，公司全资子公司美国衡健生物科技有限公司(简称“美国衡健”)的新冠抗原检测试剂(专业版)取得的CLIA证书近日生效，同时获得加拿大医疗器械注册证;控股子公司杭州莱和生物技术有限公司(简称“杭州莱和”)的四款毒品检测试剂近日取得由国家药品监督管理局(简称“NMPA”)颁发的《医疗器械注册证》(体外诊断试剂);另外，公司参与研制或生产的两款动物检测试剂被纳入由中华人民共和国农业农村部审查批准核发的新兽药注册目录/兽药产品目录。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483996847"}